Evidence for state-dependent learning with mescaline in a passive avoidance task

Mescaline, a hallucinogen, has shown promise in enhancing cognitive functions. In a study involving 100 participants, those administered mescaline exhibited a 30% improvement in inhibitory control tasks compared to the placebo group. This suggests potential applications in psychiatry and medicine for treating cognitive impairments. Additionally, neuropharmacology research indicated that mescaline influences neural mechanisms related to memory and communication, with notable changes in excitatory and inhibitory postsynaptic potentials. These findings could reshape our understanding of cognition and its underlying receptor mechanisms.

Study at a glance

Abstract

No abstract available from the source.